Quest Diagnostics Inc (DGX) Stock Price, Quote & News

Company Profile

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 973 520 2700

Website: www.questdiagnostics.com

Address:

500 Plaza Drive, Secaucus, United States

Small_time_trader Aug. 21 at 7:04 PM

$DGX Quest to parter with Mass Gen Hospital If Haystack starts to take off - look out https://clpmag.com/disease-states/cancer/mass-general-brigham-launches-clinical-trials-haystack-mrd-ctdna-testing/

0 · Reply

ZacksResearch Aug. 21 at 2:29 PM

$DGX up 20.6% in a year — is it still a buy? 🚀 Quest Diagnostics is driving growth through strategic acquisitions and double-digit revenue gains in areas like advanced cardiometabolic in the second quarter of 2025. Plus, its disciplined cost management enhances appeal. But rising debt and macroeconomic uncertainties loom large. Discover the full investment case here 👉 https://www.zacks.com/stock/news/2740891/should-quest-diagnostics-stock-be-in-your-portfolio-right-now?cid=sm-stocktwits-2-2740891-body-8802&ADID=SYND_STOCKTWITS_TWEET_2_2740891_BODY_8802

0 · Reply

ZacksResearch Aug. 21 at 1:29 PM

$DGX — buy, sell, or avoid? 🧪 The stock has been put under the microscope with a fresh look at whether Quest Diagnostics deserves a spot in your portfolio right now. Full breakdown here 👉 https://www.zacks.com/stock/news/2740891/should-quest-diagnostics-stock-be-in-your-portfolio-right-now?cid=sm-stocktwits-2-2740891-teaser-8783&ADID=SYND_STOCKTWITS_TWEET_2_2740891_TEASER_8783

0 · Reply

Small_time_trader Aug. 20 at 3:27 AM

$DGX

0 · Reply

Small_time_trader Aug. 15 at 4:05 PM

$DGX Getting comfy in the 170s Is today the day for 180 ?

0 · Reply

StockAutoPro Aug. 14 at 3:48 PM

$DGX: Buy target $175.78 Sell target $186.67 Strong diagnostics demand predicts robust growth for this leading healthcare diagnostic company.

0 · Reply

StockAutoPro Aug. 11 at 4:57 PM

$DGX: Buy target $175.45 Sell target $186.32 Rising demand for telehealth services could boost the performance of this leading digital health platform.

0 · Reply

andftbl Aug. 1 at 4:28 PM

$DGX Back up?

0 · Reply

patten1962 Jul. 30 at 12:28 PM

$DGX https://newsroom.questdiagnostics.com/2025-07-29-Athena-Diagnostics-Improves-Ataxia-Movement-Disorder-Testing-with-Novel-Long-Read-Gene-Sequencing?s=09 $PACB

0 · Reply

patten1962 Jul. 30 at 12:27 PM

$PACB Today is a great example of this Stocktwits $PACB forum. 14k followers. Maybe I wrong but I think $DGX News with PacBio is pretty positive. Very few reactions. Find it odd.

0 · Reply

Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference

Aug 13, 2025, 6:35 PM EDT - 9 days ago

Quest Diagnostics Declares Quarterly Cash Dividend

Aug 7, 2025, 9:08 AM EDT - 15 days ago

Mass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-surgical Treatment for Two Cancer Types

Aug 5, 2025, 8:33 AM EDT - 17 days ago

Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care

Jul 29, 2025, 8:52 AM EDT - 24 days ago

Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

PACB

Jul 22, 2025, 1:10 PM EDT - 4 weeks ago

Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks

Jul 22, 2025, 12:22 PM EDT - 4 weeks ago

Quest Diagnostics Incorporated (DGX) Q2 2025 Earnings Call Transcript

Jul 22, 2025, 7:17 AM EDT - 4 weeks ago

Quest Diagnostics raises annual forecasts on strong diagnostic testing demand

Jul 22, 2025, 6:47 AM EDT - 4 weeks ago

Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025

Jul 15, 2025, 7:57 AM EDT - 5 weeks ago

Quest Diagnostics Introduces Testing for Oropouche Virus

Jul 15, 2025, 7:36 AM EDT - 5 weeks ago

Quest Diagnostics: Buy Into Future Patient Demand, At An Undervalued Price Today

Jul 9, 2025, 8:24 AM EDT - 6 weeks ago

Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease

Jun 25, 2025, 9:07 AM EDT - 2 months ago

Quest Diagnostics Releases 2024 Corporate Responsibility Report

Jun 23, 2025, 10:52 AM EDT - 2 months ago

Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025

Jun 10, 2025, 8:03 AM EDT - 2 months ago

Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology

May 20, 2025, 8:52 AM EDT - 3 months ago

More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals

May 16, 2025, 1:11 PM EDT - 3 months ago

Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference

May 13, 2025, 6:03 AM EDT - 3 months ago

Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds

May 3, 2025, 4:26 AM EDT - 3 months ago

Quest Diagnostics: A Leader But Waiting For Better Price

Apr 23, 2025, 1:17 PM EDT - 4 months ago

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings

Apr 22, 2025, 12:09 PM EDT - 4 months ago

Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence

Apr 22, 2025, 11:39 AM EDT - 4 months ago

Quest Diagnostics Incorporated (DGX) Q1 2025 Earnings Call Transcript

Apr 22, 2025, 7:37 AM EDT - 4 months ago

Quest beats quarterly profit estimates on strong demand for diagnostic tests

Apr 22, 2025, 7:01 AM EDT - 4 months ago

Quest Diagnostics earnings beat after March rebound in demand from slump early in the quarter

Apr 22, 2025, 6:43 AM EDT - 4 months ago

Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025

Apr 9, 2025, 7:53 AM EDT - 4 months ago

Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease

Apr 4, 2025, 1:43 PM EDT - 5 months ago

8 Upcoming Dividend Increases During Volatile Times

AMT BKU GD KAI ORCL REIT RNP

Apr 2, 2025, 7:06 AM EDT - 5 months ago

Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening

Apr 1, 2025, 4:23 PM EDT - 5 months ago

Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025

Mar 19, 2025, 7:52 AM EDT - 5 months ago

Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day

Mar 18, 2025, 9:00 AM EDT - 5 months ago

Quest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI

Feb 24, 2025, 8:00 AM EST - 6 months ago

Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

FMS

Feb 13, 2025, 4:54 PM EST - 6 months ago

Quest Diagnostics to Host Investor Day on March 19, 2025

Feb 12, 2025, 9:00 AM EST - 6 months ago

GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System

GRAL

Jan 30, 2025, 4:14 PM EST - 7 months ago

Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year

Jan 30, 2025, 2:35 PM EST - 7 months ago

Quest Diagnostics Incorporated (DGX) Q4 2024 Earnings Call Transcript

Jan 30, 2025, 6:45 AM EST - 7 months ago

Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share

Jan 27, 2025, 8:56 AM EST - 7 months ago

Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals

Jan 8, 2025, 8:42 AM EST - 8 months ago

Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer

Jan 2, 2025, 11:00 AM EST - 8 months ago

Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025

Dec 3, 2024, 9:50 AM EST - 9 months ago

Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference

Dec 3, 2024, 8:23 AM EST - 9 months ago

Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health

Nov 25, 2024, 10:44 AM EST - 9 months ago

15 stocks — including Palantir and Nvidia — whose sales estimates have risen the most this earnings season

NVDA PLTR APH ATO BLK CNC CTRA

Nov 15, 2024, 1:05 PM EST - 10 months ago

Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management

Oct 24, 2024, 10:10 AM EDT - 10 months ago

Quest Diagnostics Has Massive Secular Tailwinds And A Strong Base

Oct 24, 2024, 8:36 AM EDT - 10 months ago

Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat

Oct 23, 2024, 8:08 AM EDT - 10 months ago

US lab operator Quest Diagnostics to launch bird flu test at end of October

Oct 23, 2024, 7:53 AM EDT - 10 months ago

Quest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development

Oct 22, 2024, 4:57 PM EDT - 10 months ago

Overlooked Stock: DGX

Oct 22, 2024, 11:40 AM EDT - 10 months ago

Quest Diagnostics (DGX) Q3 2024 Earnings Call Transcript

Small_time_trader Aug. 21 at 7:04 PM

0 · Reply

ZacksResearch Aug. 21 at 2:29 PM

0 · Reply

ZacksResearch Aug. 21 at 1:29 PM

0 · Reply

Small_time_trader Aug. 20 at 3:27 AM

$DGX

0 · Reply

Small_time_trader Aug. 15 at 4:05 PM

$DGX Getting comfy in the 170s Is today the day for 180 ?

0 · Reply

StockAutoPro Aug. 14 at 3:48 PM

$DGX: Buy target $175.78 Sell target $186.67 Strong diagnostics demand predicts robust growth for this leading healthcare diagnostic company.

0 · Reply

StockAutoPro Aug. 11 at 4:57 PM

$DGX: Buy target $175.45 Sell target $186.32 Rising demand for telehealth services could boost the performance of this leading digital health platform.

0 · Reply

andftbl Aug. 1 at 4:28 PM

$DGX Back up?

0 · Reply

patten1962 Jul. 30 at 12:28 PM

$DGX https://newsroom.questdiagnostics.com/2025-07-29-Athena-Diagnostics-Improves-Ataxia-Movement-Disorder-Testing-with-Novel-Long-Read-Gene-Sequencing?s=09 $PACB

0 · Reply

patten1962 Jul. 30 at 12:27 PM

$PACB Today is a great example of this Stocktwits $PACB forum. 14k followers. Maybe I wrong but I think $DGX News with PacBio is pretty positive. Very few reactions. Find it odd.

0 · Reply

NVDAMillionaire Jul. 28 at 4:52 PM

$DGX Brilliant piece that captures DGX's situation perfectly. So if you want to update your understanding of DGX or get to know DGX better, this is essential reading. https://beyondspx.com/article/quest-diagnostics-powering-growth-through-precision-and-strategic-expansion-nyse-dgx

0 · Reply

ChillllinTheMost Jul. 28 at 1:21 PM

$VCYT am I the only one that seems like a $DGX $LH or $TEM could come in and buy this cash rich company?

0 · Reply

andftbl Jul. 24 at 2:01 PM

$DGX this looks really promising

0 · Reply

JarvisFlow Jul. 23 at 7:07 PM

UBS has updated their rating for Quest Diagnostics ( $DGX ) to Neutral with a price target of 180.

0 · Reply

JarvisFlow Jul. 23 at 2:58 PM

Truist Securities has updated their rating for Quest Diagnostics ( $DGX ) to Hold with a price target of 192.

0 · Reply

JarvisFlow Jul. 23 at 2:26 PM

Deutsche Bank updates rating for Quest Diagnostics ( $DGX ) to Hold, target set at 160 → 178.

0 · Reply

Small_time_trader Jul. 22 at 3:36 PM

$DGX Jim Davis be like

0 · Reply

Small_time_trader Jul. 22 at 1:52 PM

$DGX Printing $$

0 · Reply

ZacksResearch Jul. 22 at 1:45 PM

$DGX crushes Q2 estimates — what’s driving the growth? 🚀 ⚡ EPS beat by 1.9% and revenue surged 15.2% YoY 📈 Volumes up 16.3% with strategic execution supporting growth 🔮 Raised full-year guidance adds more appeal See the full breakdown here 👉 https://www.zacks.com/stock/news/2602868/quest-diagnostics-beats-q2-earnings-revenue-estimates-stock-rises?cid=sm-stocktwits-2-2602868-body-2966&ADID=SYND_STOCKTWITS_TWEET_2_2602868_BODY_2966

0 · Reply

ZacksResearch Jul. 22 at 11:55 AM

$DGX just crushed Q2 — is this the breakout bulls were waiting for? 15.2% revenue growth and a big EPS beat pushed the stock up 3.2% pre-market. Full breakdown here 👉 https://www.zacks.com/stock/news/2602868/quest-diagnostics-beats-q2-earnings-revenue-estimates-stock-rises?cid=sm-stocktwits-2-2602868-teaser-2961&ADID=SYND_STOCKTWITS_TWEET_2_2602868_TEASER_2961

0 · Reply

DonCorleone77 Jul. 22 at 11:00 AM

$DGX Quest Diagnostics raises FY25 adjusted EPS view to $9.63-$9.83 from $9.55-$9.80 -- Consensus $9.70.

0 · Reply

DonCorleone77 Jul. 22 at 10:58 AM

$DGX Quest Diagnostics reports Q2 adjusted EPS $2.62, consensus $2.58 -- Q2 revenue $2.76B, consensus $2.73B.

0 · Reply

Market Cap	20.54B
Revenue (ttm)	9.87B
Net Income (ttm)	871.00M
EPS (ttm)	N/A
PE Ratio	19.70
Forward PE	18.94
Profit Margin	8.82%
Debt to Equity Ratio	0.78

Volume	947,700
Avg Vol	1,086,280
Day's Range	N/A - N/A
Shares Out	111.82M
Stochastic %K	46%
Beta	0.46
Analysts	Sell
Price Target	$188.71